Company will present promising preliminary progression-free survival and overall survival data for patients with combined positive score (CPS) ≥20 Conference […]
ROCKVILLE, Md., May 30, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and […]